Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on Sales

Cresco Labs (CRLBF) EBT Margin (2020 - 2025)

Historic EBT Margin for Cresco Labs (CRLBF) over the last 6 years, with Q3 2025 value amounting to 6.13%.

  • Cresco Labs' EBT Margin fell 124200.0% to 6.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78%, marking a year-over-year decrease of 6600.0%. This contributed to the annual value of 1.47% for FY2024, which is 175900.0% up from last year.
  • According to the latest figures from Q3 2025, Cresco Labs' EBT Margin is 6.13%, which was down 124200.0% from 1.68% recorded in Q2 2025.
  • Cresco Labs' 5-year EBT Margin high stood at 8.65% for Q1 2024, and its period low was 128.02% during Q3 2021.
  • Over the past 5 years, Cresco Labs' median EBT Margin value was 0.4% (recorded in 2022), while the average stood at 18.84%.
  • Within the past 5 years, the most significant YoY rise in Cresco Labs' EBT Margin was 4748600bps (2021), while the steepest drop was -1382500bps (2021).
  • Over the past 5 years, Cresco Labs' EBT Margin (Quarter) stood at 5.33% in 2021, then plummeted by -1573bps to 78.6% in 2022, then surged by 109bps to 6.81% in 2023, then tumbled by -74bps to 1.74% in 2024, then crashed by -453bps to 6.13% in 2025.
  • Its EBT Margin stands at 6.13% for Q3 2025, versus 1.68% for Q2 2025 and 0.55% for Q1 2025.